NeuPharma Announces the Initiation of Phase I Clinical Trial of Novel Na+/K+-ATPase Inhibitor RX108 in Cancer Patients SUZHOU, China, June 08, 2015 (GLOBE NEWSWIRE) -- Suzhou NeuPharma Co., Ltd. today announced that it has initiated the first-in-human Phase I clinical trial of RX108 in Australia.  RX108 is a...